DocGo Inc. (DCGO)
USD 2.15
(-2.05%)
USD 2.15
(-2.05%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 624.28 Million USD | 41.72% |
| 2022 | 440.51 Million USD | 38.21% |
| 2021 | 318.71 Million USD | 238.74% |
| 2020 | 94.09 Million USD | 94.81% |
| 2019 | 48.29 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 164.94 Million USD | -14.13% |
| 2024 Q1 | 192.08 Million USD | -3.59% |
| 2023 FY | 624.28 Million USD | 41.72% |
| 2023 Q2 | 125.48 Million USD | 11.05% |
| 2023 Q4 | 199.24 Million USD | 6.8% |
| 2023 Q1 | 113 Million USD | 3.88% |
| 2023 Q3 | 186.55 Million USD | 48.66% |
| 2022 Q2 | 109.51 Million USD | -7.1% |
| 2022 Q1 | 117.89 Million USD | -2.83% |
| 2022 FY | 440.51 Million USD | 38.21% |
| 2022 Q4 | 108.78 Million USD | 4.28% |
| 2022 Q3 | 104.31 Million USD | -4.75% |
| 2021 Q1 | 49.68 Million USD | 59.05% |
| 2021 Q4 | 121.32 Million USD | 41.34% |
| 2021 Q3 | 85.83 Million USD | 38.04% |
| 2021 Q2 | 62.18 Million USD | 25.15% |
| 2021 FY | 318.71 Million USD | 238.74% |
| 2020 Q2 | 22.53 Million USD | 68.47% |
| 2020 Q1 | 13.37 Million USD | 0.0% |
| 2020 Q4 | 31.24 Million USD | 15.98% |
| 2020 FY | 94.09 Million USD | 94.81% |
| 2020 Q3 | 26.93 Million USD | 19.52% |
| 2019 FY | 48.29 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 78.684% |
| Addus HomeCare Corporation | 1.05 Billion USD | 41.03% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -218.65% |
| Amedisys, Inc. | 2.23 Billion USD | 72.085% |
| American Oncology Network, Inc. | 1.27 Billion USD | 51.196% |
| Astrana Health, Inc. | 1.38 Billion USD | 54.979% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 67.06% |
| IMAC Holdings, Inc. | 5.19 Million USD | -11912.481% |
| biote Corp. | 185.36 Million USD | -236.798% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -1891.752% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 69.09% |
| COMPASS Pathways plc | - USD | -Infinity% |
| The Ensign Group, Inc. | 3.72 Billion USD | 83.26% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 62.649% |
| InnovAge Holding Corp. | 763.85 Million USD | 18.271% |
| Assure Holdings Corp. | 255 Thousand USD | -244719.075% |
| The Joint Corp. | 117.69 Million USD | -430.423% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 40.863% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -5926.815% |
| ModivCare Inc. | 2.75 Billion USD | 77.308% |
| NewGenIvf Group Limited | 5.13 Million USD | -12054.791% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -4865.699% |
| Option Care Health, Inc. | 4.3 Billion USD | 85.49% |
| P3 Health Partners Inc. | 1.26 Billion USD | 50.703% |
| P3 Health Partners Inc. | 1.26 Billion USD | 50.703% |
| The Pennant Group, Inc. | 544.89 Million USD | -14.571% |
| Surgery Partners, Inc. | 2.74 Billion USD | 77.243% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -11219.535% |
| Talkspace, Inc. | 150.04 Million USD | -316.068% |
| Talkspace, Inc. | 150.04 Million USD | -316.068% |
| The Oncology Institute, Inc. | 324.23 Million USD | -92.54% |
| The Oncology Institute, Inc. | 324.23 Million USD | -92.54% |